Received May 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
suspecetd vaccination failure; but two years later I got shingles while we were on vacation; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix and Shingrix. On an unknown date, 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: suspecetd vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: but two years later I got shingles while we were on vacation). The patient was treated with antivirals. The outcome of the vaccination failure was not reported and the outcome of the shingles was resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. The company considered the vaccination failure to be unrelated to Shingrix and Shingrix. It was unknown if the company considered the shingles to be related to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 17-MAY-2026. This case was reported by a patient via interactive digital media. The patient had received both Shingrix shots, but two years later they developed shingles while on vacation. It required two rounds of antiviral medication to clear. The patient shuddered to think that it might have been worse if they had not received the vaccine. The batch number was not provided and unable to contact the reporter. This case was considered as suspected vaccination failure as details regarding laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: A case of Vaccination failure, 2 years after receiving 1st dose and 2nd dose of Shingrix in a patient. Case lacks further information on medical history, concurrent conditions and laboratory confirmation. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.